Friday, 22 May 2020

Proactive Investors Interview May 22: BioLargo CEO Discusses Clyraguard




BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive that Clyraguard, a spray developed by its subsidiary Clyra Medical Technologies, was shown to cause complete inactivation of the coronavirus in lab testing.

Calvert says Clyraguard is a personal protective spray designed to help frontline healthcare workers prevent cross-contamination of their personal protective equipment from the coronavirus.

No comments:

Post a comment